StreetInsider.com News Articles

Form 8-K BIO KEY INTERNATIONAL For: Jul 02

Thu, 09 Jul 2026 16:49:00 -0400

si-local-file:///var/storage/secattach/20260709/26753770.html

Form 8-K BIO KEY INTERNATIONAL For: Jul 07

Tue, 07 Jul 2026 08:45:00 -0400

si-local-file:///var/storage/secattach/20260707/26739314.html

Form 8-K BIO KEY INTERNATIONAL For: Jul 07

Tue, 07 Jul 2026 08:45:00 -0400

si-local-file:///var/storage/secattach/20260707/26739314.html

BIO-key regains Nasdaq compliance, trading set to resume

Tue, 07 Jul 2026 07:58:13 -0400

BIO-key International, Inc. (NASDAQ: BKYI) announced that its common stock will resume trading on the Nasdaq Capital Market on July 8, 2026, following a period of suspension.

The Nasdaq Stock Market LLC notified BIO-key that trading would recommence after a June 16 hearing before a Nasdaq Hearings Panel. The panel determined that the company had regained compliance with Nasdaq's continued listing standards, including minimum bid price and SEC filing requirements.

As a condition of reinstatement, BIO-key will be subject to a Discretionary Panel Monitor under Nasdaq Rule 5815(d)(4)(B) for one year, through July 6, 2027.

CEO Michael DePasquale said, "We are grateful to

BIO-key regains Nasdaq compliance, trading set to resume

Tue, 07 Jul 2026 07:58:13 -0400

BIO-key International, Inc. (NASDAQ: BKYI) announced that its common stock will resume trading on the Nasdaq Capital Market on July 8, 2026, following a period of suspension.

As a condition of reinstatement, BIO-key will be subject to a Discretionary Panel Monitor under Nasdaq Rule 5815(d)(4)(B) for one year, through July 6, 2027.

CEO Michael DePasquale said, "We are grateful to

BIO-key regains Nasdaq compliance, trading set to resume

Tue, 07 Jul 2026 07:58:13 -0400

BIO-key International, Inc. (NASDAQ: BKYI) announced that its common stock will resume trading on the Nasdaq Capital Market on July 8, 2026, following a period of suspension.

As a condition of reinstatement, BIO-key will be subject to a Discretionary Panel Monitor under Nasdaq Rule 5815(d)(4)(B) for one year, through July 6, 2027.

CEO Michael DePasquale said, "We are grateful to

BIO-key regains Nasdaq compliance, trading set to resume

Tue, 07 Jul 2026 07:58:13 -0400

BIO-key International, Inc. (NASDAQ: BKYI) announced that its common stock will resume trading on the Nasdaq Capital Market on July 8, 2026, following a period of suspension.

As a condition of reinstatement, BIO-key will be subject to a Discretionary Panel Monitor under Nasdaq Rule 5815(d)(4)(B) for one year, through July 6, 2027.

CEO Michael DePasquale said, "We are grateful to

BIO-key Regains Compliance with Nasdaq Listing Rules; Nasdaq Trading Resumes on Wednesday, July 8th

Tue, 07 Jul 2026 07:58:00 -0400

HOLMDEL, N.J., July 07, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (Nasdaq: BKYI), a global leader in Identity and Access Management and biometric authentication technologies, today announced that The Nasdaq Stock Market LLC has notified it that the trading of its common stock will recommence on the Nasdaq Capital Market effective with markets’ opening on Wednesday, July 8, 2026.